Organizing Committee
OCM Member
The Ohio State University Comprehensive Cancer Center , USA
Biography :

Clara D. Bloomfield, MD is a Distinguished University Professor at The Ohio State University (OSU) and holder of the William Greenville Pace III Endowed Chair in Cancer Research. Dr. Bloomfield is an internationally recognized clinical scientist whose over 45 years of ground breaking research on adult leukemia and lymphoma, described in over 1080 publications, have changed the way we think about these diseases and treat these patients. The recipient of many prestigious honors, Dr. Bloomfield is an elected member of the Institute of Medicine of the National Academy of Sciences and of the American Academy of Arts & Sciences.

Research Interest :

Leukemia, Myeloid, Acute, Leukemia, Cancer, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Chromosome Aberrations, Lymphoma, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Trisomy, Leukemia, Promyelocytic, Acute

OCM Member
Professor and Vice Chair of Medicine
University of Massachusetts Medical School , USA
Biography :

Gyongyi Szabo, MD, PhD is the Worcester Foundation for Biomedical Research Endowed Chair, Professor and Vice Chair of Medicine and Associate Provost at the University of Massachusetts Medical School. She is an internationally recognized leader in the field of liver immunology and inflammation. Her clinical investigations focus on alcoholic hepatitis, non-alcoholic fatty liver disease and viral hepatitis, and her laboratory studies molecular mechanisms of inflammation and innate immunity in liver injury to identify therapeutic targets in liver diseases. She is an expert in Toll-like and Nod-like receptor signaling pathways in alcoholic and non-alcoholic liver diseases. Her investigations recently revealed the importance of micro-RNAs and extracellular vesicles in liver diseases. She is a member of the Hungarian Academy of Sciences, Editor-in-Chief of Hepatology Communications, serves on Advisory Boards for NIH and several leading academic institutions, and is Immediate Past President of the American Association for the Study of Liver Diseases (AASLD).

OCM Member
Head, Medicinal Chemistry Section, Center for Biomolecular Therapeutics (CBT), Dept. of Pharmacology
University of Maryland School of Medicine , USA
Biography :

Professor Vincent Njar completed his B. Sc. in Chemistry at University of Ibadan (the top University in Nigeria) in 1976 and went on to obtain a Ph.D. in Organic Chemistry in 1980 from University College London/University of London, (UK) under the supervision of Derek V. Banthorpe. Following two years of postdoctoral research with the late Eliahu Caspi at Worcester Foundation for Experimental Biology, Shrewsbury, Mass. (USA), he joined the Department of Chemistry at the University of Ibadan (Nigeria) as Lecturer II. He was promoted through the ranks and became Professor of Organic Chemistry in 1996. During his tenure at University of Ibadan, he was visiting Professor at several institutions, including: Johns Hopkins University, Baltimore, USA (1988, 1989, 1992 & 1993); Universite de Sherbrooke, Sherbrooke, Quebec, Canada (1990); University of Southampton, Southampton, UK (1991, 1992 & 1995); and University of Saarland, Saarbruecken, Germany (1994-1995). Following several research visits from 1996 to 1998 collaborating with the late Dr. Angela Brodie at University of Maryland School of Medicine, Baltimore (UMSOM), internationally renowned breast and prostate cancer researcher, he immigrated to the US in 1999. He is currently Professor of Medicinal Chemistry and Pharmacology, Department of Pharmacology and Head, Medicinal Chemistry Section of Center for Biomolecular Therapeutics (CBT), University of Maryland School of Medicine, Baltimore, MD, USA. Professor Njar has published >120 articles, reviews and book chapters and is the lead inventor on over 50 issued patents and pending patent applications. On 85% of these, he is first or senior/corresponding author. Professor Njar actively participates in several drug discovery and development grant review committees nationally and internationally. His research is currently supported by the US National Institutes of Health (NIH) and the National Cancer Institute (NCI). He is co-founder of Isoprene Pharmaceuticals Inc., a company focused on the development of therapies for oncology and dermatological diseases.

OCM Member
The World Academy of Medical Sciences , Netherlands
Biography :

Dr. Shevchenko is the Chairman of the WAMS International Board of Biotechnology/Medical Technology, Executive Board Member of the WAMS International Medical Research Council (IMREC), Chairman of the WAMS Ukrainian Committee, Fellow of the Academy & Member of the WAMS Executive Council (WAMS Executive Board), and Academy Professor of Medicine at WAMS. Dr. Shevchenko has a MSc degree in Biochemistry and Molecular Biology at the Botany Institute of the Ukrainian Academy of Sciences, he is Doctor of Medicine from the Kharkov National Medical University. In 1990, together with Prof. Sjoerd Bulstr, Dr. Shevchenko initiated the Dutch - Ukrainian Program on Orthopaedic Devices and Biomaterials in Maastrict, Netherlands.

Research Interest :

Dr. Shevchenko combines his vision in translational medical science for therapeutics with extraordinarily moral values and ethics. By pushing cutting-edge biotechnology solutions with the goal of redefining how complex medical situations are treated, Dr. Shevchenko guides us as a true hero and leader at the World Academy of Medical Sciences. It is my honor to learn from him and support him on his current and future projects, as we aim to create a better world, as brothers. He has my respect and admiration always.

OCM Member
Department of Medicine
University of Massachusetts Medical School , USA
Biography :

Shaoguang Li obtained his PhD degree from Tulane University, USA, and did his postdoctoral studies at Harvard Medical School. He is currently a professor at University of Massachusetts Medical School, USA. He has published some seminal work related to leukemia stem cells in highly competitive journals such as Nature Genetics, JCI, PNAS, Blood, Leukemia, etc.

Research Interest :

Medicinal Chemistry, oncopharmacology, anti-cancer drug discovery and development, small-molecule design and synthesis, cancers (breast, prostate, pancrease, skin), steroidal compounds, retinoidal compounds, steroid and retinoid-mimetics, pharmacokinetics, anti-tumor xenograft studies, inhibitors of CYP26, CYP17 and CYP19 (aromatase), AR antagonists, AR/AR-Vs degraders, Mnk1/2 degraders, inhibitors of oncogenic protein translation, Mnk1/2, eukaryotic translation initiation factor 4F/ eukaryotic initiation factor 4E, inhibitors of tumor growth and metastasis, mechanisms of action of anti-cancer agents.

Allied Academies Global Conference Directory

Mail us at

Program Enquiry
biomarkers@molecularbiologyconferences.com
Sponsorship/Exhibitor/Advertising
sponsoraac@alliedacademies.com
General Queries
biomarkers@molecularbiologyconferences.com
More details about sponsorship:sponsors@alliedacademies.com

Terms and Conditions


Responsibility

Delegates are personally responsible for their belongings at the venue. The Organizers will not be held responsible for any stolen or missing items belonging to Delegates, Speakers or Attendees; due to any reason whatsoever.


Insurance

Registration fees do not include insurance of any kind.


Transportation

Please note that any (or) all transportation and parking is the responsibility of the registrant.


Press/Media

Press permission must be obtained from Allied Academies Organizing Committee prior to the event. The press will not quote speakers or delegates unless they have obtained their approval in writing. The Allied academies are a non-profit organization. This conference is not associated with any commercial meeting company.


Requesting an Invitation Letter

For security purposes, letter of invitation will be sent only to those individuals who had registered for the conference. Once your registration is complete, please contact biomarkers@molecularbiologyconference.com to request a personalized letter of invitation.

Regarding refunds, all bank charges will be for the registrant's account. Cancellation, Postponement, Transfer of Registration and all cancellations or modifications of registration must be made in writing to Program Manager (biomarkers@molecularbiologyconference.com or biomarkerconferences@gmail.com)
.

Cancellation Policy

If Allied academies cancel this event for any reason, you will receive a credit for 100% of the registration fee paid. You may use this credit for another Allied Academies Conferences (AAC) event which must occur within one year from the date of cancellation.


Postponement

If Allied academies postpone an event for any reason and you are unable or unwilling to attend on rescheduled dates, you will receive a credit for 100% of the registration fee paid. You may use this credit for another Allied Academies Conferences event which must occur within one year from the date of postponement.


Transfer of registration

All fully paid registrations are transferable to other persons from the same organization if registered person is unable to attend the event. Transfers must be made by the registered person in writing to Program Manager. Details must be included with the full name of replacement person, their title, contact phone number and email address. All other registration details will be assigned to the new person unless otherwise specified.

Registration can be transferred to one conference to another conference of Allied academies if the person is unable to attend one of the conferences. However, Registration cannot be transferred if it is intimated within 14 days of the respective conference. The transferred registrations will not be eligible for Refund.


Visa Information

Keeping in view of increased security measures, we would like to request all the participants to apply for Visa as soon as possible. Allied Academies will not directly contact embassies and consulates on behalf of visa applicants. All delegates or invitees should apply for Business Visa only. Important note for failed visa applications: Visa issues cannot come under the consideration of cancellation policy of Allied Academies, including the inability to obtain a visa.


Refund Policy

If the registrant is unable to attend and is not in a position to transfer his/her participation to another person or event, then the following refund arrangements apply, Keeping in view of advance payments towards Venue, Printing, Shipping, Hotels and other overheads, we had to keep refund policy is as following slabs-

Before 60 days of the conference: Eligible for Full Refund less $100 Service Fee
Within 60-30 days of Conference: Eligible for 50% of payment Refund
Within 30 days of Conference: Not eligible for Refund
E-Poster Payments will not be refunded.


Accommodation Cancellation Policy

Accommodation Providers (Hotels) have their own cancellation policies, and they generally apply when cancellations are made less than 30 days prior to arrival. Please contact us as soon as possible, if you wish to cancel or amend your accommodation. Allied Academies will advise the cancellation policy of your accommodation provider, prior to cancelling or amending your booking, to ensure you are fully aware of any non-refundable deposits.


Copyright © 2018-2019 Allied Academies, All Rights Reserved.